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An increased intestinal permeability is associated with several diseases. Nutrition can influence gut permeability. Previously, we showed that
dietary Ca decreases whereas dietary short-chain fructo-oligosaccharides (scFOS) increase intestinal permeability in rats. However, it is unknown
how and where in the gastrointestinal tract Ca and scFOS exert their effects. Rats were fed a Western low-Ca control diet, or a similar diet
supplemented with either Ca or scFOS. Lactulose plus mannitol and Cr-EDTA were added to the diets to quantify small and total gastrointestinal
permeability, respectively. Additionally, colonic tissue was mounted in Ussing chambers and exposed to faecal water of these rats. Dietary Ca
immediately decreased urinary Cr-EDTA excretion by 24 % in Ca-fed rats compared with control rats. Dietary scFOS increased total
Cr-EDTA permeability gradually with time, likely reflecting relatively slow gut microbiota adaptations, which finally resulted in a 30 % increase.
The lactulose:mannitol ratio was 15 % higher for Ca-fed rats and 16 % lower for scFOS-fed rats compared with control rats. However, no dietary
effect was present on individual urinary lactulose and mannitol excretion. The faecal waters did not influence colonic permeability in Ussing
chambers. In conclusion, despite effects on the lactulose:mannitol ratio, individual lactulose values did not alter, indicating that diet did not influ-
ence small-intestinal permeability. Therefore, both nutrients affect permeability only in the colon: Ca decreases, while scFOS increase colonic
permeability. As faecal water did not influence permeability in Ussing chambers, probably modulation of mucins and/or microbiota is important
for the in vivo effects of dietary Ca and scFOS.
Calcium: Short-chain fructo-oligosaccharides: Intestinal permeability: Diet
The intestinal epithelial cell layer constitutes the largest and
most important barrier against the external environment.
Tight contact between the enterocytes prevents access of
intraluminal toxins, antigens and enteric microbiota to
underlying tissue compartments. A compromised intestinal
barrier function is suggested to be associated with the
pathogenesis of a number of intestinal diseases including
inflammatory bowel disease, coeliac disease, post-infectious
irritable bowel syndrome and food allergy(1 – 4). Accumulating
evidence about the progression of inflammatory bowel
disease, a chronic relapsing and remitting disease for which
the aetiology remains unknown, shows that an increased
intestinal permeability intensifies the exposure of the lamina
propria to luminal contents, activating an abnormal immune
response(3,5).
Interestingly, nutrition can affect the epithelial barrier, and
hence possibly influence disease development. We have
shown in several controlled studies that dietary Ca protects
against intestinal infections with foodborne pathogens(6 – 8).
Ca also has cytoprotective effects by precipitating cytotoxic
surfactants, such as secondary bile acids(9,10). In addition, sup-
plemental Ca attenuates the development of colitis(11). In the
latter study, total intestinal permeability was quantified by
the analysis of urinary Cr-EDTA excretion. We observed
that supplemental Ca prevented the colitis-related increase in
intestinal permeability in HLA-B27 transgenic rats(11).
Another example of dietary modulation of intestinal
permeability is the supplementation of short-chain fructo-
oligosaccharides (scFOS), which may be regarded as a pre-
biotic. Work from our group has shown that these dietary
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scFOS impair the resistance to intestinal infection in
rats(8,12,13). Subsequently, we showed that this decrease in
barrier functioning was associated with a higher total intestinal
permeability in rats(14).
The dietary effects on intestinal permeability in the studies
mentioned earlier were investigated by the addition of
Cr-EDTA to the diet and subsequent measurement of urinary
Cr-EDTA excretion. As Cr-EDTA is stable throughout the
intestinal tract, the urinary excretion of this marker provides
information regarding total intestinal permeability(15).
By choosing permeability probes that have limited exposure
to certain parts of the intestinal epithelium, region-specific
permeability measurements can be performed(16). For
example, the saccharide probes lactulose and mannitol can
be used to measure small-intestinal permeability, because
they are instantly degraded by the colonic microbiota. Since
lactulose only passes the gut wall paracellularly and mannitol
passes transcellularly, the lactulose:mannitol ratio is used
to express small-intestinal permeability(2).
We hypothesised that both a high-Ca diet and a scFOS diet
mainly influence colonic permeability. As colitis is suggested
to result from increased translocation of micro-organisms due
to a higher colonic permeability and Ca attenuated colitis
development(11), dietary Ca probably has its main effect on
permeability of the colon. Since scFOS are fermented in the
colon, where they change the luminal content, which possibly
influences the colonic mucosa, we also hypothesised that
scFOS mainly affect colonic permeability. The aim of the
present study was to localise these effects. Therefore,
we added Cr-EDTA, lactulose and mannitol as permeability
markers to the rat diets. As no specific colonic permeability
marker exists, this can be determined by comparing total
(Cr-EDTA) and small (lactulose:mannitol ratio) intestinal
permeability. To gain even more insight into the effect
of dietary Ca and scFOS on permeability, we performed
Ussing chamber experiments with the faecal waters derived
from the in vivo study.
Material and methods
Experimental design of the nutritional study: animals
and diets
The experimental protocol was approved by the Animal
Welfare Committee of Wageningen University and Research
Centre (Wageningen, The Netherlands). Specific pathogen-
free outbred male Wistar rats (WU, Harlan, Horst, The
Netherlands), 8 weeks old and with a mean body weight of
267 g at the start of the experiment, were housed individually
in metabolic cages. Rats were maintained in temperature- and
humidity-controlled environment in a 12 h light–dark cycle.
Rats were fed ad libitum a purified ‘humanised’ Western
diet which contained in the control situation (per kg): 200 g
acid casein, 326 g maize starch, 162 g glucose, 160 g palm
oil, 40 g maize oil, 50 g cellulose and 5·16 g CaHPO4.2H2O
(corresponding to 30 mmol Ca/kg diet; Sigma-Aldrich,
St Louis, MO, USA). In addition, the diets contained the
following permeability markers per kg: 2 g Cr-EDTA, 7·5 g
lactulose (Solvay Arzneimittel GmbH, Hannover, Germany)
and 2·5 g mannitol (Sigma-Aldrich) (see below). Lactulose
and mannitol were added to the diet to avoid stressful
supplementation by oral gavage which might have an impact
on intestinal permeability and transit time. Moreover, the
continuous exposure of the rats to the permeability probes
excludes a possible day–night rhythm in intestinal per-
meability. Vitamins and minerals (other than Ca) were
added to both the diets according to AIN-93(17). This control
diet was low in Ca and had a high fat content to mimic the
composition of a Western human diet. The diet high in Ca
contained 120 mmol Ca/kg diet, and in the scFOS group, the
control diet was supplemented with 60 g scFOS/kg diet
(6 % (w/w); Raftilose wP95, Orafti, Tienen, Belgium), both
at the expense of glucose. The degree of polymerisation of
the supplemented scFOS ranges between 2 and 8, and there-
fore they are classified as scFOS. Inert Cr-EDTA was added
to the diets to quantify total intestinal permeability(18).
Cr-EDTA solution was prepared as described elsewhere
and subsequently freeze dried(19). To check the complete
formation of the Cr-EDTA complex, the prepared Cr-EDTA
solution was passed through a cation-exchange resin column
(Chelex 100 Resin; Bio-Rad, Hercules, CA, USA). No uncom-
plexed Cr3þ ions were present. Potential binding and
subsequent precipitation of Cr-EDTA to Ca were determined
by quantification of the Cr-EDTA concentration in the faecal
water. This was similar in the different dietary groups,
so binding of Cr-EDTA to Ca was concluded to be absent.
Small-intestinal permeability was assessed using lactulose
and mannitol(2,20). Food intake was recorded daily, and animal
weight was recorded three times every week. After 14 d of
experimental feeding, rats were anaesthetised with isoflurane
and killed.
Measurement of intestinal permeability
Total 24 h urine samples were collected every 2 d during the
experiment. For Cr-EDTA measurement, urine was acidified
with 50 g/l TCA, centrifuged for 2 min at 14 000 g and diluted
with 0·5 g/l CsCl. Then, Cr was analysed by inductively
coupled plasma-atomic emission spectrophotometry. Urinary
lactulose and mannitol were analysed by high-performance
anion-exchange chromatography with pulsed amperometric
detection on a Au electrode. The analyses were performed
with a 600E System controller pump (Waters, Milford, MA,
USA) with a He degassing unit and a model 400 EC detector
(EG&G, Princeton, NJ, USA). With a WPS-3000 autosampler
(Dionex, Sunnyvale, CA, USA), 20ml of the (diluted) sample
were injected on a Carbopac MA-1, 250 £ 4 mm, column
(Dionex) thermostated at 308C. Lactulose and mannitol were
eluted isocratically at a flow rate of 0·40 ml/min with
480 mM-NaOH followed by a washing step of 1000 mM-
NaOH and 1000 mM-sodium acetate. Data analysis was done
with Chromeleon software version 6.60 (Dionex).
Ussing chambers
All faeces were collected on the last 3 d of the nutritional
experiment and freeze dried. Faecal water was prepared as
described earlier(21). The animal welfare committee of Utrecht
University (Utrecht, The Netherlands) approved the animal
protocol. Specific pathogen-free outbred male Wistar rats
(n 6; WU), 7–8 weeks old, were killed by CO2 inhalation.
The colon was taken out and washed in Ringer solution

















(25 mM-NaHCO3, 117·5 mM-NaCl, 1·25 mM-CaCl2, 5·7 mM-KCl,
1·2 mM-NaH2PO4, 1·2 mM-MgSO4 and 5 g glucose, pH 7·4
when gassed with 95 % O2–5 % CO2 at 378C), and its muscle
layers were stripped off. The tissue sections were cut into spe-
cimens of appropriate size and randomly mounted in Ussing
chambers (manufactured by Technical Services of Utrecht
Institute for Pharmaceutical Sciences), each side containing
the Ringer solution. After a 30 min equilibration period, base-
line transepithelial resistance was measured, and the Ringer
solution in the mucosal compartment was replaced by fresh
Ringer solution (negative control), or Ringer solution contain-
ing no Ca, or faecal water prepared from faeces of the differ-
ent dietary groups of the nutritional study described earlier.
Colonic tissue was thus exposed to faecal water pools of
either control rats, Ca-fed rats or scFOS-fed rats. The Ca che-
lator ethylene glycol tetraacetic acid served as a positive con-
trol for enhanced permeability due to Ca binding (8 mM as
final concentration in Ringer solution in both compartments).
At the same time, fluorescein isothiocyanate-labelled 4 kDa
dextran (FITC-dextran) was added at the mucosal side
(1 mg/ml as final concentration). Samples were taken every
30 min from the serosal compartment for subsequent fluor-
escence measurement and replaced by fresh Ringer solution.
The experiment was carried out for 180 min, after which end-
line transepithelial resistance was determined. Flux was
expressed as nanomol of FITC-dextran crossing 1 cm2 of colo-
nic epithelium in 1 h (nmol/cm2 per h).
Statistical analysis
All the results are expressed as means with their standard
errors. The predefined comparisons of interest for the nutri-
tional study were control rats v. Ca-fed rats and control rats
v. scFOS-fed rats. For the in vitro experiments, the predefined
comparisons of interest were: faecal water of control rats v.
faecal water of Ca-fed rats, faecal water of control rats
v. faecal water of scFOS-fed rats and the negative control v.
withdrawal of Ca from the Ringer solution. Statistics were
done by one-way ANOVA or Kruskal–Wallis test, depending
on the normality of the data. If significant, this was followed
by Student’s t test (for normally distributed data) or Mann–
Whitney U test (for non-normally distributed data) to identify
the significant dietary effects. Differences were considered
statistically significant when P,0·05 (all two-sided). Statis-
tical analyses were conducted with GraphPad Prism version
5.01 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Animal growth and food intake
Rats fed the high-Ca diet did not differ from rats fed the
low-Ca control diet with respect to growth (5·8 (SE 0·3) and
6·3 (SE 0·3) g/d, respectively; P¼0·16). However, animal
growth in the scFOS group was significantly lower (4·7 (SE
0·3) g/d, P¼0·0002) in accordance with a previous study(12).
Food intake of rats fed the low-Ca control diet and of rats
fed the high-Ca diet was similar (21·6 (SE 0·4) and 21·4
(SE 0·5) g/d, respectively; P¼0·72), while food intake of the
scFOS-fed rats was significantly less than that of control rats
(18·4 (SE 0·4) g/d, P,0·0001).
Dietary calcium and short-chain fructo-oligosaccharides
influence total intestinal permeability
Dietary Ca supplementation caused a direct and persistent
decrease in urinary Cr-EDTA excretion; the decrease was
24 % in rats fed the high-Ca diet compared with rats fed
the low-Ca control diet on day 14 (P,0·05; Fig. 1). Urinary
excretion of Cr-EDTA by scFOS-fed rats was lower than
that by control rats at the beginning of the experiment
(day 2). This might represent shorter exposure of the
intestinal epithelium to luminal contents due to more rapid
gut transit on the scFOS diet, which has been observed in
past studies(22). From day 2, urinary Cr-EDTA excretion by
scFOS-fed rats increased gradually with time compared with
the control group, probably reflecting relatively slow gut
microbiota adaptations due to scFOS. After 2 weeks, dietary
scFOS had increased total intestinal permeability by 30 %
(P,0·05; Fig. 1).
Effect of calcium and short-chain fructo-oligosaccharides on
small-intestinal permeability
Dietary effects on the lactulose:mannitol ratio were smaller
and, surprisingly, in the opposite direction compared to total
intestinal permeability as measured by Cr-EDTA. The lactulo-
se:mannitol ratio on day 14 was 15 % higher for rats fed the
high-Ca diet (0·23 (SE 0·006), P¼0·0014) and 16 % lower
for rats fed the scFOS diet (0·17 (SE 0·009), P¼0·0038) com-
pared with rats fed the low-Ca control diet (0·20 (SE 0·005)).
We also considered the lactulose and mannitol fluxes indi-
vidually to gain more insight and specify whether paracellular
permeability was changed. However, we did not observe
significant dietary effects on individual lactulose (P¼0·61)
and mannitol excretion in urine (P¼0·36; Fig. 2). This indi-
cates that paracellular permeability in the small intestine
remained the same. In combination with the Cr-EDTA results,
it can therefore be concluded that both Ca and scFOS affect

































Fig. 1. Effect of dietary Ca and short-chain fructo-oligosaccharides (scFOS)
on urinary Cr-EDTA excretion, a marker for total intestinal paracellular
permeability. Results are expressed as means with their standard errors
(n 13). * Mean values of Ca-fed rats were significantly different compared
with control rats (P,0·05). † Mean values of scFOS-fed rats were
significantly different compared with control rats (P,0·05). –W–, Control;
–X–, Ca; –D–, scFOS.

















Effect of faecal water from rats fed supplemental calcium or
short-chain fructo-oligosaccharides in Ussing chambers
Faecal waters were prepared from faeces of the in vivo rat
experiment and tested in Ussing chambers using colonic
tissue. Diet influenced the pH of pools of faecal water
(control: 6·1; Ca: 6·5 and scFOS: 5·5). No dietary effects
were observed on transepithelial resistance (P¼0·23), while
the positive control (ethylene glycol tetraacetic acid) caused a
decrease in resistance as expected (P¼0·0019; data not
shown). Also, the paracellular flux of FITC-dextran crossing
the epithelial barrier was similar for all faecal waters at all
time points (P¼0·67; Fig. 3). Obviously, the FITC-dextran
flux was increased in the positive control due to the addition of
the Ca chelator ethylene glycol tetraacetic acid (P ¼ 0·0002).
So, diet-modified faecal waters did not influence colonic per-
meability in Ussing chambers. Furthermore, the Ca-free
Ringer solution at the luminal side of the Ussing chamber
did not influence dextran flux either (P¼0·09; Fig. 3).
Discussion
The present study demonstrates that the effect of dietary
Ca and scFOS on permeability in rats is localised in the
colon. Supplemental Ca clearly decreased total intestinal
permeability, as determined by Cr-EDTA as a marker. At
the same time, it caused a less pronounced increase in the
lactulose:mannitol ratio but without affecting the individual
lactulose excretion, representing small-bowel permeability.
Taken together, it can be concluded, although indirectly, that
the overall permeability is decreased by Ca supplementation
and that the effect is localised in the colon. The same applies
for scFOS, although the results are opposite: dietary scFOS
increased total intestinal permeability as measured by
Cr-EDTA, whereas a minor decrease in the lactulose:mannitol
ratio was observed without an effect on individual urinary
lactulose values. Therefore, we can indirectly conclude that
the increase in permeability caused by scFOS is also localised
in the colon. The Ussing chamber experiments showed that
dietary Ca and scFOS did not influence colonic permeability
via alterations in faecal water.
The consistent finding that dietary Ca beneficially influ-
ences colonic permeability is very interesting. In the first
place, it is intriguing that intestinal permeability apparently
can be improved in a healthy situation. Secondly, an increased
permeability is suggested to be a primary causative factor con-
tributing to inflammatory bowel disease pathogenesis(2,23,24).
It is generally accepted that the gut microbiota and its intimate
contact with an over-reactive immune system in the intestinal
epithelium is the driving force behind the chronic inflam-
mation(25). As intestinal bacteria reside mainly in the
colon(26), decreasing of colonic permeability by a high-Ca
diet might be a highly attractive nutritional intervention for
inflammatory bowel disease patients. Moreover, in a previous
study, we showed that supplemental Ca attenuated some
important aspects of colitis development in HLA-B27 trans-
genic rats(11).
Based on the individual lactulose results, dietary Ca does
not influence small-intestinal permeability. The fact that
Meddings & Gibbons(16) could not detect any lactulose and
mannitol in the colon underlines the specificity of both
lactulose and mannitol as markers for small-intestinal
permeability. Therefore, Ca supplementation might only be
worthwhile when targeting the colon for health improvement.
The reason for the difference in localisation is unknown, but
we hypothesise that Ca influences intestinal permeability by
modulating the colonic microbiota or its metabolites.
For example, Salmonella typhi and Escherichia coli, being
members of the enterobacteria, are able to induce an increase
in intestinal permeability(27). In agreement with these results,
dietary Ca decreased faecal enterobacteria in the present
study (control: 9·1 (SE 0·2); Ca: 7·3 (SE 0·1) and scFOS: 9·1
(SE 0·1) log10 colony-forming units/g faeces). Effects of both
Ca and scFOS on the intestinal microbiota have been shown
before(8,13,14,28).






















Fig. 3. Effect of faecal water from rats fed a control diet, Ca-
supplemented diet or short-chain fructo-oligosaccharides (scFOS)-
supplemented diet on fluorescein isothiocyanate-labelled 4 kDa dextran
(FIFC-dextran) flux, a marker for permeability, across stripped colonic tissue
in Ussing chambers. Also, the Ca-free Ringer solution at the luminal side of
the Ussing chamber was studied (‘no Ca’). Results (means with their
standard errors) are expressed as nanomol of FITC-dextran crossing 1 cm2
of colonic epithelium in 1 h. The interval of time shown (60–90 min) is repre-
sentative for the whole experiment. Negative (Ringer), n 12; positive (ethyl-
ene glycol tetraacetic acid in Ringer), n 10; faecal water of control rats, n 9;
faecal water of Ca-fed rats, n 10; faecal water of scFOS-fed rats, n 9; no

















































Fig. 2. Effect of dietary Ca and short-chain fructo-oligosaccharides (scFOS)
on individual urinary lactulose and mannitol excretion. Results are expressed
as means with their standard errors (n 13). A, Control; , Ca; B, scFOS.

















Also, the increase in total permeability caused by dietary
scFOS is shown to be localised in the colon. This was
hypothesised, as these carbohydrates, or prebiotics, are rapidly
hydrolysed and metabolised in the colon by the endogenous
microbiota(29). In this way, scFOS change the bacterial
composition, which is often assumed to be beneficial(30). In
the present study, scFOS were supplemented, which have a
degree of polymerisation ranging from 2 to 8. Supplemen-
tation with long-chain FOS (degree of polymerisation between
2 and 60) alters the microbiota differently from supplemen-
tation with scFOS, because of differences in fermentation
rate(31) and amount and pattern of SCFA production(32). How-
ever, Ten Bruggencate et al.(8) showed that scFOS and inulin
(mix of short-chain and long-chain FOS; average degree of
polymerisation between 10 and 12) both impaired resistance
to intestinal infection in rats. On the contrary, Petersen
et al.(33) only observed increased translocation of Salmonella
in mice supplemented with scFOS, and not in mice supple-
mented with inulin. The decreased food intake of the rats
fed scFOS might be due to rapid and extensive fermentation
of scFOS causing bloating and abdominal cramps(34). These
unpleasant feelings decrease appetite. As the permeability
marker data are expressed as percentage of intake, the
differences in food intake do not influence the outcome
measurements. The Cr-EDTA excretion increased gradually
with time in the scFOS group. This might reflect relatively
slow gut microbiota adaptations due to scFOS. The change
in the intestinal permeability by supplemental scFOS has
previously been associated with a decreased resistance to
intestinal infections(14).
Paracellular permeability in the small intestine, determined
by individual lactulose excretion, was not significantly
influenced by the supplementation of scFOS to the diet. A
similar site-specific effect of scFOS has been observed in pre-
vious studies in our laboratory. In one study, dietary scFOS
increased mucosal inflammation in the caecum and colon
after oral infection with Salmonella enteritidis, but not in
the ileum(12). In another study, scFOS supplementation
increased mucin concentration and stimulated mucosal lacto-
bacilli and enterobacteria in the caecum and colon, but
again not in the ileum(14). scFOS therefore clearly have
region-specific effects in rats: in the colon they may exert
undesirable effects, while in the small intestine no such effects
were observed. Results fit with the idea that the physiological
effects of scFOS are microbiota mediated and these mainly
reside in the caecum and colon. Furthermore, although
fermentation in the rat takes place in both the caecum and
colon, the similarity of the effects of scFOS in both these
organs supports the use of the rat as an appropriate model
for human colonic fermentation.
Interestingly, most adverse effects of scFOS on intestinal
infection, which are mentioned in this paper(12 – 14), were
inhibited when Ca was supplemented to the diet(8). The Ca
content of the control diet in these studies and the present
investigation matches with the lower limit of the human
intake range, while the Ca-supplemented diet provided more
than the general habitual dietary Ca intake(11,35). The dose
of scFOS used in the present study (6 %) is high, but probably
realistic for the human situation. Daily intake of fructose-
based non-digestible carbohydrates has been estimated up to
10 g(36). This corresponds to 2 % in the diet, assuming a
total food intake of 500 g dry weight/d. This estimation does
not take into account consumption of specific meals and
products supplemented with fructose-based carbohydrates,
typically 3–10 g/portion(37). As the human diet still contains
other non-digestible carbohydrates, supplementation with
6 % is high, but certainly not unrealistic. When scFOS are
fermented, SCFA are produced, which lead to acidification
of the intestinal lumen. Subsequently, the protective effect
of supplemental Ca might be due to formation of the insoluble
calcium phosphate complex in the small intestine. In the
colon, solubilisation of this complex increases the buffering
capacity of the intestinal lumen, which may counteract the
adverse effects of acidic fermentation of scFOS(38). Indeed,
the pH of faecal water of the rats fed the high-Ca diet was
higher than that of the rats fed the low-Ca control diet.
It will be interesting to investigate the effect on intestinal
permeability when both Ca and scFOS are supplemented to
the diet. This will be further explored in following studies.
Finally, when studying the effects of non-digestible carbo-
hydrates, Ca content of the diet should be taken into account.
Since the individual lactulose and mannitol excretion in
urine were not influenced by the different diets, the relevance
of the lactulose:mannitol ratio is questionable. Bijlsma et al.(39)
suggested that the individual lactulose and mannitol excretion
values provide more information than the ratio of the two
sugars. In fact, mannitol excretion in urine depends mainly
on the magnitude of solvent drag caused by villus tip hyper-
osmolality, while urinary lactulose results truly represent
paracellular permeability. By combining the two probes in a
ratio, the information is lost and wrong conclusions can be
drawn. For example, in the case of coeliac disease, mannitol
excretion is clearly decreased because of villus atrophy,
while urinary lactulose recovery is increased(40). These find-
ings are more informative than a ratio. In the present study,
the ratio indicates that dietary effects exist, while the indivi-
dual lactulose and mannitol results are not affected by the
diet. Based on these findings, we conclude that small-intestinal
permeability is not changed by Ca or scFOS.
In the Ussing chamber experiments, we did not observe any
effect of the different faecal waters, prepared from faeces of
the nutritional study, on permeability. Nevertheless, the pH
of the faecal waters was different due to the diets. This
demonstrates that fermentation of scFOS indeed influenced
colonic contents, supporting the use of faecal water to study
the potential scFOS effects. These Ussing chamber results
suggest that the effect of Ca and scFOS on colonic
permeability is not mediated by differences in faecal water
composition. Although we observed a change in cytotoxicity
of faecal water by Ca and scFOS in previous studies(7,12,13,41),
apparently luminal cytotoxicity is not responsible for the
effects on colonic permeability. However, it should be kept
in mind that, for example, SCFA produced by scFOS fermen-
tation are rapidly absorbed by the colonic mucosa and there-
fore are largely absent in faecal waters(42), although they
might have been capable of influencing the gut wall in vivo
and thus the permeability. Additionally, exposure time of the
colonic tissue to the faecal water in the Ussing chamber
is much shorter than that occurs in vivo. Nevertheless,
we hypothesise that other mechanisms, which cannot
be mimicked in the Ussing chamber, may play a role in
the effects of Ca and scFOS on permeability. A possible

















hypothesis is that Ca influences the viscosity of the mucus
layer, thereby altering intestinal permeability(43). Handling
the colonic tissue for use in the Ussing chambers results in
partial loss of this layer, hence this effect may be missed.
Moreover, as mentioned earlier and described in other
papers, both Ca and scFOS modulate the intestinal micro-
biota(12,28), and these microbes are not present in the Ussing
chambers or in the different faecal waters used in the
experiments.
Although extracellular Ca is crucial for the maintenance of
intestinal tight junction function in cell studies(44), no direct
effect of Ca on permeability in Ussing chambers was observed
when colonic tissue was exposed to Ca-free Ringer solution on
the luminal side. These differences in observation suggest that
the effect of Ca on permeability as observed in vivo is either
indirect or long term or both.
In conclusion, the present study shows that dietary Ca
decreases, while scFOS increase the permeability of the rat
colon. We hypothesise that modulation of mucins and/or
microbiota is important for the permeability effects of both
Ca and scFOS, since in vivo results could not be mimicked
in Ussing chambers. The results of the present study empha-
sise that nutrition can play an important role in the modulation
of gut epithelial integrity.
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